Key result
Cumulative non-HDL-C from adolescence to mid-adulthood is linked to ~50% greater CAC risk per unit.
Why the study?
The study was conducted to assess the association of non-high-density lipoprotein-cholesterol levels measured in adolescence with coronary artery calcification in adulthood.
Does elevated non-HDL-C in adolescence increase the risk of coronary artery calcification in adulthood?
Cohort (n=589)
Yes
Does elevated non-HDL-C in adolescence increase the risk of coronary artery calcification in adulthood?
Elevated non-HDL-C concentrations in adolescence are strongly associated with the development of coronary artery calcification in mid-adulthood, highlighting the potential importance of early pediatric lipid screening.
Answers are grounded in this paper and cite their sources.
May inform earlier non-HDL-C screening in adolescents; extends prior evidence on cumulative exposure to adult coronary calcification.
Source: Armstrong MK, Fraser BJ, Hartiala O, et al. Association of non–high-density lipoprotein cholesterol measured in adolescence, young adulthood, and mid-adulthood with coronary artery calcification measured in mid-adulthood [published online ahead of print January 27, 2021]. JAMA Cardiol. doi:10.1001/jamacardio.2020.7238lInvestigators from multiple institutions conducted a prospective cohort study to assess the association of non-high-density lipoprotein-cholesterol (non-HDL-C) levels measured in adolescence with coronary artery calcification (CAC) in adulthood. Adults were eligible if they participated in the Cardiovascular Risk in Young Finns Study (CRYFS) and were age 12-18 years at the time of CRYFS enrollment in 1980. All CRYFS participants had fasting total cholesterol and HDL-C levels drawn at enrollment and at 3-year increments through age 45. CRYFS participants now 40-46 years old were invited to participate in the current study and receive a computed tomography scan to measure CAC. Demographics, blood pressure, smoking habits, use of lipid-lowering and anti-hypertensive medications, as well as family history of heart disease was collected at enrollment in the current study.The primary exposure was non-HDL-C concentration at 3 life stages: adolescence (12-18 years old), young adulthood (21-30 years old), and mid-adulthood (33-45 years old). Non-HDL-C was calculated as total cholesterol minus HDL-C concentration (with elevated non-HDL-C levels being ≥144.79 mg/dL in adolescence and ≥189.58 mg/dL in adulthood). The primary outcome was CAC, determined using a standardized methodology and categorized as present or absent. Investigators assessed the association of non-HDL-C concentrations cumulatively and at each of the 3 life stages, with presence of CAC adjusted for potential confounders.There were 589 participants included in analysis. Mean non-HDL-C concentrations among participants increased across the 3 life stages (139 mg/dL, 146.72 mg/dL, and 154.44 mg/dL during adolescence, young adulthood, and mid-adulthood, respectively). The proportion of participants with elevated non-HDL-C concentrations varied across life stages (37.4%, 6.6%, and 10.2% in adolescence, young adulthood, and mid-adulthood, respectively). Overall, 19.2% of participants had CAC. There was a 1.5-unit increased cumulative odds for CAC with each 1-unit increase in non-HDL-C (adjusted odds ratio [aOR], 1.50; 95% CI, 1.14, 1.92). The highest life stage-specific odds for CAC was provided by non-HDL-C during adolescence.The investigators conclude that non-HDL-C concentrations are associated with CAC in adulthood, with adolescent non-HDL-C concentrations showing the strongest association.Dr Doolittle has disclosed no financial relationship relevant to this commentary. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.The current investigators highlight an important, often overlooked, aspect of pediatric primary care: Adult chronic diseases begin in childhood. The current study is particularly notable due to its large number of participants (589) and long duration of regular follow-up (every 3 years for 28 years). Prior studies have shown similar findings. Beginning in the 1990s, the Bogalusa Study was perhaps the earliest, and it demonstrated that adolescent obesity was associated with increased carotid intima thickness, a marker of early vascular disease.1 In the Muscatine Study, childhood weight was associated with CAC.2 In the CARDIA Study, multiple childhood risk factors, including obesity and LDL-C, also were associated with CAC in mid-adulthood.3The findings of the current study are compelling and challenge the pediatric community to be more thoughtful in screening for modifiable factors that comport significant downstream comorbidity. Presently, the US Preventive Task Force does not recommend universal lipid screening among children due to lack of compelling evidence for hard clinical endpoints.4 Since 1992, the American Academy of Pediatrics has recommended an individualized approach for lipid screening based on family history of premature heart disease or dyslipidemia.5 However, the National Heart Lung and Blood Institute does recommend universal screening between 9-11 years old and 17-19 years old.6 However, 70% of pediatricians do not screen for dyslipidemia among their patients aged 9-17 years.7 Given this strong association between adolescent lipid disorders and CAC, is it time to rethink our screening criteria?One challenge is what to do with the result. Only those children with the highest LDL-C levels (>189.58 mg/dL), after several attempts at dietary modification, currently are recommended for medical therapy.6 Presumably, pediatricians should be counseling all patients to follow a healthy lifestyle as part of routine well child care. What difference would checking lipids make? The momentum of this longitudinal population study begs for a next step: a randomized controlled trial.Non HDL-C levels in adolescence, early adulthood, and mid-adulthood are associated with CAC in mid-adulthood.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted a cohort in Coronary artery calcification (n=589). Non-high-density lipoprotein cholesterol (non-HDL-C) was evaluated on Coronary artery calcification (CAC) (aOR 1.50, 95% CI 1.14-1.92). Cumulative non-HDL-C concentrations from adolescence to mid-adulthood were associated with increased odds of coronary artery calcification.
Synapse has enriched 10 related papers. Consider them for comparative context: